Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Shanghai Allist Pharmaceuticals Co. Ltd. A (SSE:688578), currently being evaluated. In 2025, Shanghai Allist Pharmaceuticals Co. Ltd. A generated $5.17 Billion in revenue and $2.14 Billion in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Shanghai Allist Pharmaceuticals Co. Ltd. A is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: N/A
- Recent Revenue (2025): $5.17 Billion
- Free Cash Flow (2025): $2.14 Billion
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.